1. Home
  2. GPRE vs EVO Comparison

GPRE vs EVO Comparison

Compare GPRE & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Green Plains Inc.

GPRE

Green Plains Inc.

N/A

Current Price

$16.17

Market Cap

812.2M

Sector

Industrials

ML Signal

N/A

Logo Evotec SE

EVO

Evotec SE

N/A

Current Price

$1.90

Market Cap

778.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GPRE
EVO
Founded
2004
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
812.2M
778.3M
IPO Year
2004
2007

Fundamental Metrics

Financial Performance
Metric
GPRE
EVO
Price
$16.17
$1.90
Analyst Decision
Buy
Strong Buy
Analyst Count
7
1
Target Price
$12.57
$7.00
AVG Volume (30 Days)
1.2M
45.9K
Earning Date
05-07-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.25
N/A
Revenue
$2,091,680,000.00
N/A
Revenue This Year
N/A
$1.37
Revenue Next Year
$11.85
$10.05
P/E Ratio
$12.91
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.54
$1.90
52 Week High
$19.65
$4.27

Technical Indicators

Market Signals
Indicator
GPRE
EVO
Relative Strength Index (RSI) 49.85 35.64
Support Level $13.95 N/A
Resistance Level $16.69 $3.84
Average True Range (ATR) 0.76 0.05
MACD -0.04 0.02
Stochastic Oscillator 51.15 0.97

Price Performance

Historical Comparison
GPRE
EVO

About GPRE Green Plains Inc.

Green Plains Inc manufactures and sells ethanol and ethanol byproducts in two segments based on function. The ethanol production segment, which generates the majority of revenue, includes the production of ethanol, distillers grains, Ultra-High Protein and renewable corn oil. The agribusiness and energy services segment includes grain handling and storage, commodity marketing and merchant trading for company-produced and third-party ethanol, distillers grains, Ultra-High Protein, renewable corn oil, natural gas and other commodities.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: